Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss REGN - Regeneron Pharmaceuticals, Inc.
-7.9 M
LAST VALUE
81.81%
2 YEAR CAGR
-6.57%
5 YEAR CAGR
-1.42%
10 YEAR CAGR